Biomarkers Of Disease

This research area investigates biological indicators, or biomarkers, that signal the presence or progression of disease. Scientists in this field explore molecular, cellular, and physiological changes that can be measured to diagnose conditions, predict disease risk, monitor treatment effectiveness, and understand disease mechanisms. Research encompasses the development and validation of novel biomarkers, often utilizing advanced analytical techniques such as genomics, proteomics, and metabolomics. Key areas of focus include identifying biomarkers for infectious diseases, chronic conditions like kidney disease and cardiovascular issues, and understanding the effects of environmental exposures on health.

The study of disease biomarkers holds significant relevance for Arkansas. It directly supports the state's agricultural and manufacturing sectors by informing toxicological assessments and ensuring product safety. Furthermore, understanding biomarkers contributes to improving public health outcomes by enabling earlier disease detection and more personalized treatment strategies, particularly for prevalent conditions within the state. Research in this area also aids in evaluating the health impacts of environmental factors relevant to Arkansas's natural resources and diverse population.

Work in this area is inherently interdisciplinary, drawing on expertise from toxicology, immunology, pharmacology, and clinical medicine. Connections are actively maintained with research on infectious diseases, particularly COVID-19, as well as studies on cardiovascular health, kidney disease, and child and adolescent health. This collaborative approach spans multiple institutions across Arkansas, fostering a comprehensive understanding of disease at the molecular level.